Mereo BioPharma Group plc American Depositary Shares (MREO)
Stock · NASDAQ · Health Care
$0.2936as of 10/16/2026
Price chart
Active signals
MREO Signal Track Record
How signals performed across all stocks →What MREO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 42 | +1.0% | 50% | September 18, 2026 |
| Bollinger Band Breakdown | 23 | +10.1% | 57% | August 28, 2026 |
| Bollinger Band Breakout | 16 | +2.1% | 56% | September 22, 2026 |
| 200-Day Moving Average TouchActive now | 8 | -15.3% | 13% | December 8, 2025 |
| Any 20-session window (baseline) | -1.5% | 46% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MREO
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and Vantictumab,…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 39
- Website
- www.mereobiopharma.com/
Fundamentals
- 1-day range
- $0.2974$0.32
- Market cap
- $47.46M
- P/E (trailing)
- —
- P/E (forward)
- -13.48
- EPS (trailing)
- $-0.03
- Dividend yield
- —
- Beta
- 0.13
- Avg. volume
- 4.11M
How Mereo BioPharma Group plc American Depositary Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 19, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
Mereo BioPharma Group plc American Depositary Shares Competitors
Chosen by industry and closest market cap.
- MREOMereo BioPharma Group plc American Depositary Shares$0.303▼ 1.94%Market cap $47.46MP/E —$0.2$2.37
- MCRBSeres Therapeutics Inc. Common Stock$2.46▼ 2.77%Market cap $48.42MP/E —$2.8$29.98
- FLNAFilana Therapeutics Inc. Common Stock$0.7▼ 7.89%Market cap $46.33MP/E —$0.6701$2.27
- TCRTAlaunos Therapeutics Inc. Common Stock$2.63▲ 20.64%Market cap $48.60MP/E —$0.719$4.5
- IBOImpact BioMedical Inc. Common Stock$2.68▼ 15.14%Market cap $48.61MP/E 61.61$4.67$10.47
- CNTXContext Therapeutics Inc. Common Stock$0.244▲ 1.24%Market cap $46.31MP/E —$0.2501$3.62
- EDSAEdesa Biotech Inc. Common Shares$2.57▼ 3.75%Market cap $44.90MP/E —$0.72$20.32
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MREO Mereo BioPharma Group plc American Depositary Shares | $47.46M | — | $0.303 | ▼ 1.94% | $0.2$2.37 |
| MCRB Seres Therapeutics Inc. Common Stock | $48.42M | — | $2.46 | ▼ 2.77% | $2.8$29.98 |
| FLNA Filana Therapeutics Inc. Common Stock | $46.33M | — | $0.7 | ▼ 7.89% | $0.6701$2.27 |
| TCRT Alaunos Therapeutics Inc. Common Stock | $48.60M | — | $2.63 | ▲ 20.64% | $0.719$4.5 |
| IBO Impact BioMedical Inc. Common Stock | $48.61M | 61.61 | $2.68 | ▼ 15.14% | $4.67$10.47 |
| CNTX Context Therapeutics Inc. Common Stock | $46.31M | — | $0.244 | ▲ 1.24% | $0.2501$3.62 |
| EDSA Edesa Biotech Inc. Common Shares | $44.90M | — | $2.57 | ▼ 3.75% | $0.72$20.32 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 76.26M
- Total value held
- $25.08M
- Institutional holders
- 63
- Unknown15.31M
- Unknown13.37M
- Unknown12.00M
- Unknown8.20M
- Unknown7.56M
- Unknown7.08M
- Unknown3.56M
- Unknown2.04M
- Unknown1.49M
- Unknown796.0K
See the full, filterable feed with live charts on the MarketWall dashboard.